Clinical trial

Stalevo in Early Wearing-Off Patients

NCT00125567

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-08-01

PhasePHASE4

Study timeline

Study start (unknown)2005-08-01Date precision: month

Registry last updated2009-06-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Idiopathic Parkinson's Diseaseunresolved

Interventions

Stalevo (levodopa/carbidopa/entacapone)DRUG

Levodopa/carbidopaDRUG

Sponsors & collaborators

Orion Corporation, Orion Pharmalead sponsor

Mapped research locations

HamburgGermany1 CopenhagenDenmark1 DublinIreland1 UlmGermany1 DüsseldorfGermany1 MalmöSweden1 BristolUnited Kingdom1 TampereFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00125567 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.